FindMyKOL
Clinical trialNCT01705054CompletedObservational

Angina Prevalence and Provider Evaluation of Angina Relief

NCT01705054 is an observational study sponsored by Saint Luke's Health System. As of 21 Nov 2026, it is completed. It studies Stable Coronary Artery Disease CAD. The registry lists an enrollment of 1,246 participants at 1 site in 1 country. The registry lists a start date of 31 Jul 2013 and a primary completion date of 31 Jul 2015. One of its registered investigators has a FindMyKOL profile.

SponsorSaint Luke's Health System →Enrollment1,246Stable Coronary Artery Disease CAD
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01705054
FieldValue
Registry IDNCT01705054
StatusCompleted
Study typeObservational study
Lead sponsorSaint Luke's Health System
Enrollment1,246
Registered sites1
Countries1
ConditionsStable Coronary Artery Disease CAD
Start31 Jul 2013
Primary completion31 Jul 2015
Study completion22 Jul 2015
Last update posted19 Oct 2021

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is describe the frequency of chest pain and how chest pain impacts patients' quality of life in the outpatients with chronic coronary artery disease in contemporary cardiology practice settings.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Missouri, United States1 site
  • Saint Luke's Hospital of Kansas City

    Kansas City

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouri: 1 siteMO1KentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01705054

Each answer restates registry values shown on this page.

What is NCT01705054?

NCT01705054 is an observational study sponsored by Saint Luke's Health System. It studies Stable Coronary Artery Disease CAD.

Who leads NCT01705054?

The registry names Faraz Kureshi, MD (principal investigator, St. Luke's Hospital, Kansas City, Missouri) and John A Spertus, MD, MPH (principal investigator, St. Luke's Hospital, Kansas City, Missouri) as overall officials.

Where does NCT01705054 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT01705054 end?

The registry lists a primary completion date of 31 Jul 2015 and a study completion date of 22 Jul 2015. The sponsor last updated the record on 19 Oct 2021.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.